Louis Kayitalire - Nov 2, 2021 Form 4 Insider Report for F-star Therapeutics, Inc. (FSTX)

Role
Chief Medical Officer
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Stock symbol
FSTX
Transactions as of
Nov 2, 2021
Transactions value $
-$437
Form type
4
Date filed
11/4/2021, 09:34 PM
Previous filing
Oct 6, 2021
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FSTX Common Stock Sale -$266 -39 -0.07% $6.81 54.3K Nov 2, 2021 Direct F1, F2
transaction FSTX Common Stock Sale -$171 -25 -0.05% $6.85 54.3K Nov 2, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
F2 Includes 45,443 restricted stock units.